openPR Logo
Press release

Treatments Of Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis

09-01-2017 01:31 PM CET | Health & Medicine

Press release from: Cardiovascular Disease

Market Research Report

Market Research Report

Researchmoz added Most up-to-date research on "Treatments Of Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis" to its huge collection of research reports.

The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia, which accelerate the development of atherosclerotic plaque building up within blood vessels. As atheroma develops it causes the affected blood vessels to narrow, restricting blood flow to the body, brain or heart, depending on its location. It is also possible for the fibrous cap of this plaque to break off, triggering the coagulation cascade and causing a thrombus to form locally, which can completely occlude blood flow.

The treatments of CVD typically focus on prevention by controlling the risk factors of CVD. As such, the treatments usually fall within three categories: anti-hypertensives, which aim to alterblood pressure to within a normal range; anti-dyslipidemic drugs, which aim to modify lipid levels to a normal range; and anti-thrombotic drugs, which aim to either prevent a thrombus from formingby inhibiting the coagulation cascade or platelet aggregation.

There has been vast scientific innovation within the CVD therapeutics market over recent decades, particularly within the anti-dyslipidemia market, first with the introduction of statins such as Lipitor (atorvastatin), and more recently with the introduction of PCSK9 inhibitors. Innovation continues within the dyslipidemia pipeline, with a range of first-in-class molecular targets in the pipeline, including those that offer the promise of revolutionizing treatment by reversing the process of atherosclerosis.

Heart failure and pulmonary hypertension remain poorly treated, and are associated with poor prognosis. Heart failure in particular is associated with a five-year mortality rate of 50%. The large pipeline for heart failure includes a high proportion of first-in-class products relative to other CVD indications, and possesses the potential for breakthroughs in the treatment of this condition.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1313843

Scope

- With over 1,400 products in active development, the pipeline for CVD is extensive. Does current pipeline innovation hold the potential to change the CVD market in the near future?
- There are 320 first-in-class products in the CVD market that act on a novel molecular target thatis not present in an approved product across any indication in the pharmaceutical industry. Which of these hold the greatest potential to improve future disease treatment with regard to their molecular target?
- Analysis of the history of strategic consolidations revealed a modest level of deal activity in recent years, and a large number of first-in-class products not yet involved in any deals. How do deal frequency and value compare between target families and molecule types, and which first-in-class programs that have not yet been involved in a licensing or co-development deal appear to be particularly promising?

Reasons to buy

- Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
- Visualize the composition of the CVD market in terms of dominant molecule types and targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
- Analyze the CVD pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating CVD to overcome the unmet need in the market.
- Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
- Identify commercial opportunities in the CVD deals landscape by analyzing trends in licensing and co-development deals, and analyzing a curated list of CVD therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Table Of Content

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4

2 Executive Summary 6
2.1 Robust pipeline with attempts to meet unmet need 6
2.2 Drugs targeting apolipoproteins and elements of the reverse lipid transport pathway offer potential new therapies for the treatment of dyslipidemia and atherosclerosis 6
2.3 Cardiovascular disease pipeline emphasizes move away from conventional areas towards targets related to transmembrane and extracellular signaling 6

3 The Case for Innovation 7
3.1 Growing Opportunities for Biologic Products 8
3.2 Diversification of Molecular Targets 8

Browse More Details @ http://www.researchmoz.us/frontier-pharma-cardiovascular-disease-diverse-first-in-class-molecular-targets-to-bridge-unmet-needs-in-pulmonary-hypertension-heart-failure-and-atherosclerosis-report.html

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Treatments Of Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis here

News-ID: 695149 • Views:

More Releases from Cardiovascular Disease

Deep Research: Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis
Deep Research: Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class …
Researchmoz added Most up-to-date research on "Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis" to its huge collection of research reports. An insight on the important factors and trends influencing the market. The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD
Clinical Trials On Cardiovascular Disease: Frontier Pharma
Clinical Trials On Cardiovascular Disease: Frontier Pharma
Researchmoz added Most up-to-date research on "Clinical Trials On Cardiovascular Disease: Frontier Pharma" to its huge collection of research reports. The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia, which accelerate the development of atherosclerotic plaque building up within blood vessels. As atheroma develops it causes the affected blood
Market Overview of Cardiovascular Disease Industry 2018
Market Overview of Cardiovascular Disease Industry 2018
Albany, NY, 3rd January : Recent research and the current scenario as well as future market potential of "Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis" globally. The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1313843 The most crucial risk
Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis
Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unme …
Researchmoz added Most up-to-date research on "Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis" to its huge collection of research reports. The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia, which accelerate the development of atherosclerotic plaque building up

All 5 Releases


More Releases for CVD

Chemical Vapor Deposition (CVD) Equipment Market to Witness Huge Growth by 2027 …
The research and analysis conducted in Chemical Vapor Deposition (CVD) Equipment report helps clients to predict investment in an emerging market, expansion of market share or success of a new product with the help of global market research analysis. This report has been designed in such a way that it provides very evident understanding of the business environment and Chemical Vapor Deposition (CVD) Equipment industry. Nevertheless, this global market research
Semiconductor Chemical Vapor Deposition (CVD) Equipment Market 2020 Precise Outl …
The Semiconductor Chemical Vapor Deposition (CVD) Equipment Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report. Semiconductor Chemical Vapor
CVD Diamond Sales Market: The global CVD diamond sales will grow at a CAGR of 7. …
The Global CVD Diamond Sales Market 2020 Report offers entire data on the CVD Diamond Sales market. The report covers the major components such as main players, analysis, size, the situation of the business, SWOT analysis, best techniques of production, management, and marketing. Also, the report sports data in the form of tables, numbers, and charts which offer a clear view of the CVD Diamond Sales market. The latest data
Global CVD SiC Market Outlook (2014-2025)
The global CVD SiC market is valued at 130 million US$ in 2018 is expected to reach 240 million US$ by the end of 2025, growing at a CAGR of 7.3% during 2019-2025. This report focuses on CVD SiC volume and value at global level, regional level and company level. From a global perspective, this report represents overall CVD SiC market size by analyzing historical data and future prospect. Regionally, this
CVD SiC Market Size, Share, Development by 2024
Global Info Research offers a latest published report on CVD SiC Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 102 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-cvd-sic-market_p108757.html   CVD SiC is a kind of SiC materials
CVD SiC Market Size Estimation by Experts 2019
The global CVD SiC market is valued at 130 million US$ in 2018 is expected to reach 240 million US$ by the end of 2025, growing at a CAGR of 7.3% during 2019-2025. CVD SiC is a kind of SiC materials produced via Chemical Vapor Deposition(CVD) process. CVD SiC material has a unique combination of excellent thermal, electrical and chemical properties that makes it well-suited to applications across semi-conductor industries where a